Nanosonics reports solid H1 2026 growth despite market challenges

Nanosonics announced a 9% revenue increase for the first half of fiscal year 2026 despite facing margin pressures. This growth reflects the company's ability to expand sales in a challenging market, affecting investors and competitors in medical technology. The earnings call detailed factors behind the revenue rise and the squeeze on profit margins.